Metalloproteinases 1 and 7 and colorectal cancer;Metaloproteinases 1 e 7 e câncer colorretal

Revista Brasileira de Coloproctologia

Volumn 28, Issue 3, 2008, Pages 353-362

  Jucá, Mário ^a,c   Nunes, Benicio Luiz Bulhp̃es Barros Paula ^b   de Menezes, Hunaldo Lima ^b   Gomes, Edmundo Guilherme de Almeida ^a   Matos, Delcio ^b  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Universidade Federal de São Paulo ^*  (Brazil)

Author keywords

Colorectal neoplasms; Matrix metalloproteinase; Matrix metalloproteinase 1

Indexed keywords

EID: 58149177243     PISSN: 01019880     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0101-98802008000300016     Document Type: Article

References (105)

1. Coussens LM, Werb Z - Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3(11): 895-904.
2. Wu AW, Gu J, Ji JF, Li ZF, Xu GW. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis. World J Gastroenterol 2003; 9(9): 1990-1994.
3. Xiong B, Sun TJ, Hu WD, Cheng FL, Mao M, Zhou YF - Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance. World J Gastroenterol 2005; 11(8): 1105-1108.
4. Ghilardi G, Biondi ML, Mangoni J, Leviti S, Demonti M, Guagnellini E et al - Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001; 7(8): 2344-2346.
5. Wagenaar-Miller RA, Gorden L, Matrisian LM - Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 2004; 23(1-2): 119-135.
6. Murphy G, Koklitis P, Carne AF - Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. Biochem J 1989; 261(3): 1031-1034.
7. Matrisian LM - Metalloproteinases and their inhibitors in matrix remodeling. Trends genet 1990; 6(4): 121-125.
8. Liotta LA, Stetler-Stevenson WG, Steeg PS - Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 1991; 9(5): 543-51.
9. Joo YE, Seo KS, Kim J, Kim HS, Rew JS, Park CS et al - Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. J Korean Med Sci 1999; 14(4): 417-423.
10. Stetler-Stevenson WG, Yu AE - Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001; 11(2): 143-52.
11. Moilanen M, Sorsa T, Stenman M, Nyberg P, Lindy O, Vesterinen J et al - Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysis-1 (MMP-3) and degrades type I collagen. Biochemistry 2003; 42(18): 5414-5420.
12. Deryugina EI, Quigley JP - Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25(1): 9-34.
13. Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ et al - Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases. Eur J Cancer 2006; 42(3): 310-318.
14. Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R et al - Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO Journal 2004; 23(15), 3020-3030.
15. Visse R, Nagase H - Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92(8): 827-839.
16. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, Mcqueney MS et al - The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998; 273(48): 32347-32352.
17. Sternlicht MD, Werb Z - How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
18. Liotta LA - Tumor invasion and metastases - role of the extracellular matrix. Cancer Res 1986; 46(1): 1-7.
19. Mignatti P, Rifkin DB - Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73(1): 161-195.
20. Stetler-Stevenson WG, Aznavoorian S, Liotta LA - Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
21. Birkedal-Hansen H - Proteolytic remodeling of extracellular matrix. Cur Opin Cell Biol 1995; 7(5): 728-735.
22. Chambers AF, Matrisian LM - Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89(17): 1260-1270.
23. Curran S, Murray GI - Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999; 189(3): 300-308.
24. Kähäri VM, Saarialho-Kere U - Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999; 31(1): 34-45.
25. Curran S, Murray GI - Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36(13): 1621-1630.
26. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM - Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18(5): 1135-1149.
27. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I - Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 2000; 13(9): 925-933.
28. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S et al - MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000; 5(2): 108-114.
29. Stetler-Stevenson WG - The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 2001; 10(2): 383-392.
30. Stetler-Stevenson WG, Yu AE - Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001; 11(2): 143-152.
31. Yamauchi K, Ogata Y, Nagase H, Shirouzu K - Inibition of liver metastasis from orthotopically implanted colon cancer in nude mice by transfection of the TIMP-1 gene into KM12SM cells. Surg Today 2001; 31(9): 791-798.
32. Brinckerhoff CE, Matrisian LM - Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002; 3(3): 207-214.
33. Overall CM, López-Otín C - Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002; 2(9): 657-672.
34. Yana I, Seiki M - MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 2002; 19(3): 209-215.
35. Bendardaf R, Lamlum H, Vihinen P, Ristamaki R, Laine J, Pyrhonen S - Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology 2003; 65(4): 337-346.
36. Leeman MF, Curran S, Murray GI - New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003; 201(4): 528-534.
37. Stamenkovic I - Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200(4): 448-464.
38. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI - Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 2004; 10(24): 8229-8234.
39. Mariani SM - Conference report-Extracellular matrix and cancer: revisiting metalloproteinases highlights from the annual meeting of the American Society for Cell Biology; December 13-17, 2003; San Francisco, California. MedGenMed 2004; 6(1): 25.
40. Zucker S, Vacirca J - Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004; 23(1-2): 101-117.
41. Tauro JR, Gemeinhart RA - Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem 2005; 16(5): 1133-1139.
42. Westermarck J, Kähäri VM - Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13(8): 781-792.
43. Collen A, Hanemaaijer R, Lupu F, Quax PHA, Van Lent N, Grimbergen J et al - Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 2003; 101(5): 1810-1817.
44. Maskos K, Bode W - Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Mol Biotechnol 2003; 25(3): 241-266.
45. Eeckhout Y, Vaes G - Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977; 166(1): 21-31.
46. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S et al - Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997; 16(9): 2319-2332.
47. Deryugina EI, Ratnikov BI, Yu Q, Baciu PC, Rozanov DV, Strongin AY - Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in furin-negative colon carcinoma LoVo cells. Traffic 2004; 5(8): 627-641.
48. Woessner JF - Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5(8): 2145-2154.
49. Jiang Y, Goldberg ID, Shi YE - Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002; 21(14): 2245-2252.
50. Baker AH, Edwards DR, Murphy G - Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002; 115(19): 3719-3727.
51. Holten-Andersen MN, Hansen U, Brunner N, Nielsen HJ, Illemann M, Nielsen BS - Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human coloorectal adenoma and adenocarcinoma. Int J Cancer 2005; 113(2): 198-206.
52. Egeblad M, Werb Z - New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2(3): 161-174.
53. Takino T, Sato H, Shinagawa A, Seiki M - Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995; 270(39): 23013-23020.
54. Itoh Y, Nagase H - Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 1995; 270(28): 16518-16521.
55. Murray GY, Duncan ME, O'Neil P, Melvin WT, Fothergill JE - Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996; 2(4): 461-462.
56. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T et al - Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 2001; 95(5): 290-294.
57. Zeng ZS, Huang Y, Cohen AM, Guillem JG - Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14(12): 3133-3140.
58. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG - Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1995; 1(8): 899-906.
59. Ring P, Johansson K, Höyhtyä M, Rubin K, Lindmark G - Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. Br J Cancer 1997; 76(6): 805-811.
60. Gross J, Lapiere CM - Collagenolytic activity in anphibian tissues; a tissue culture assay. Proc Natl Acad Sci USA 1962; 48(6): 1014-1022.
61. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A et al - Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res 2005; 11(2-1): 594-599.
62. Sardinha TC, Nogueras JJ, Xiong H, Weiss EG, Wexner SD, Abramson S - Membrane-Type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum 2000; 43(3): 389-395.
63. Murai S, Umemiya T, Seiki M, Harigaya K - Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression. Virchows Arch 2004; 445(3): 271-278.
64. Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA et al - Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 1995; 3(6): 541-549.
65. Bode W - A helping hand for collagenases: the haemopexin-like domain. Structure 1995; 3(6): 527-530.
66. Nosho K, Yoshiday M, Yamamoto H, Taniguchi H, Adachi Y, Mikami M et al - Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Carcinogenesis 2005; 26(5): 892-899.
67. Van Der Stappen JW; Hendriks T; Wobbes T - Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 1990; 45(6): 1071-1078.
68. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S - Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 2004; 19(6): 518-524.
69. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K - Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 2003; 200(5): 568-576.
70. Baker EA, Bergin FG, Leaper DJ - Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 2000; 87(9): 1215-21.
71. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ - Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000; 149(6): 1309-1323.
72. Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H et al - Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and - independent processes. J Exp Med 2002; 195(3): 295-308.
73. López-Otín C, Overall CM - Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002; 3(7): 509-519.
74. Bertini I, Calderone V, Cosenza M. Conformational variability of matrix metalloproteinases: Beyond a single 3D structure. PNAS 2005; 102 (15): 5334-5339.
75. Hasegawa S, Koshikawa N, Momiyama N, Moriyama K, Miyazaki K, Ichikawa Y, Ichikawa T, Mitsuhashi M, Shimada H, Miyazaki K. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer in a nude mouse model. Int J Cancer 1998; 76(6): 812-816.
76. Kioi M, Yamamoto K, Higashi S, Koshikawa N, Fijita K, Miyazaki K. matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential nude mouse model. Oncogene 2003; 22(54): 8662-8670.
77. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 1999; 45(2): 252-258.
78. Nishizuka I, Ichikawa Y, Ishikawa T, Kamiyama M, Hasegawa S, Momiyama N, Miyazaki K, Shimada H. Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo. Cancer Letters 2001; 173(2): 175-182.
79. Cawston, TE. Fragments of human fibroblast collagenase. Purification and characterization. Biochem J. 1989 October 1; 263(1): 201-206.
80. Saha D, Roman C, Beauchamp D. New strategies for colorectal cancer prevention and treatment. World J Surg 2002; 26(7): 762-766.
81. Wilson CL, Matrisian LM. Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996; 28(2): 123-136.
82. Ichikawa Y, Ishikawa T, Momiyama N, Yamaguchi S, Masui H, Hasegawa S et al. Detection of regional lymph node metastase in colon cancer using RT-PCR for matrix metalloproteinase 7, matrilysin. Clin Exp Metastasis 1998; 16(1): 3-8.
83. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A, Atomi Y. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 2001; 84(10):1317-321.
84. Yanagisawa N, Geironson L, Al-Soud WA, Ljungh A. Expression of matrix metalloproteinase-2, -7 and -9 on human colon, liver and bile duct cell lines by enteric nd gastric helicobacter species. FEMS Immunol Med Microbiol 2005; 44(2): p197-204.
85. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore. Curr Opin Cell Biol. 200; 13(5):534-40.
86. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155(4): 1033-1038.
87. Sunami E, Tsuno NH, Kitayama J, Saito S, Osada T, Yamagushi H, Tomozawa S, Tsuruo T, Shibata Y, Nagawa H. Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone. Surg Today 2002; 32(4): 343-350.
88. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H et al. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991; 48(4): 550-556.
89. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H et al. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 1994; 201(2): 657-664.
90. McDonnell S, Navre M, Coffey RJ Jr, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991; 4(6): p527-533.
91. Bramhall SR, Neoptolemos JP, Stamp GW, Lemoine NR. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 1997; 182(3): 347-355.
92. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348(6303): 699-704.
93. Roeb E, Matern S. Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors. Z Gastroenterol. 200; 39(9):807-13.
94. Lew RA. The zinc metallopeptidase family: new faces, new functions. Protein Pept Lett 2004; 11(5): 407-414.
95. Wilson CL, Heppner KJ, Labosky PA, Hogan BLM, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 1997; 94(4): 1402-1407.
96. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic b-catenin and MMP-7 (matrilysin) congregate in late-stage clinical colon cancer. Gastroenterology 2002; 122(1):60-71.
97. Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, Nosho K, Min Y, Horiuchi S, Yoshida M, Itoh F, Imai K. Association of trypsin expression with tunour progression and matrilysin expression in human colorectal cancer. J Pathol 2003;199(2): 176-184.
98. Husoy T, Olstorn HB, Knutsen HK, Loberg EM, Cruciani V, Mikalsen SO, Goverud IL, Alexander J. Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells. Eur J Cancer 2004; 40(10): 1599-1603.
99. Lloyd JM, McIver CM, Stephenson SA, Hewett P, Rieger N, Hardingham JE. Identification of early-stage colorectal cancer patients at risk fo relapse post-ressection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006; 12(2): 417-423.
100. Lynch C, Crawford HC, Matrisian LM, McDonnell S. Epidermal growth factor upregulates matrix metallopreoteinase-7 expression trough activation of PEA3 transcription factors. Int J Oncol 2004; 24(6): 1565-1572.
101. Seiler N, Schneider Y, Gosse F, Schleiffer R, Raul F. Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasiveness. Int J Oncol 2004; 25(4): 1039-1048.
102. Miyazaki K, Koshikawa N, Hasegawa S, Momiyama N, Nagashima Y, Moriyama K, Ichikawa Y, Ichikawa T, Mitsuhashi M, Shimada H. Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents. Cancer Chemother Pharmacol 1999; 43(Suppl): S52-S55.
103. Kumar A, Collins H, Van Tan J, Scholefield JH, Watson AS. Effect of preoperative radiotherapy on matrilisyn gene expression in rectal cancer. Eur J Cancer 2002; 38(4): p505-510.
104. Kurokawa S, Arimura Y, Yamamoto H, Adachi Y, Endo T, Sato T, Suga T, Hosokawa M, Shinomura Y, Imai K. Tumor matrilysin expression predctis metastatic potential of stage I (pT1) colon and rectal cancers. Gut 2005; 54(12): 1751-1758.
105. Takahashi Y, Ellis LM, Mai M. The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion. Oncology Reports 2003; 10: 9-13.